Publications

Publications | Masters and Phd thesis

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

Publications

In Press | 2019 | ...

In Press

Meta-Analysis in Metastatic Uveal Melanoma to Determine Progression-Free and Overall Survival Benchmarks: an International Rare Cancers Initiative (IRCI) Ocular Melanoma study.

Khoja L., Atenafu E.G., Suciu S., Leyvraz S., Sato T., Marshall E., Keilholz U., Zimmer L., Patel S.P., Piperno-Neumann S. et al. Annals of oncology. Peer-reviewed.

[DOI][Pmid][serval:BIB_BD137DAA9150]

2019

Systemic and central nervous system metabolic alterations in Alzheimer’s disease

Ivanisevic Julijana, Popp Julius, van der Velpen Vera, Teav Tony, Gallart-Ayala Hector, Mehl Florence, Konz Ioana, Clark Christopher, Oikonomidi Aikaterini, Peyratout Gwendoline et al., 2019/12. Alzheimer's Research & Therapy. Peer-reviewed.

[DOI][serval:BIB_901648E242CF]

Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey.

Steffen T., Putora P.M., Hübner M., Gloor B., Lehmann K., Kettelhack C., Adamina M., Peterli R., Schmidt J., Ris F. et al., 2019/12. Clinical colorectal cancer, 18 (4) pp. e335-e342. Peer-reviewed.

[DOI][Pmid][serval:BIB_A52BDCE5AABD]

CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.

Salomé B., Gomez-Cadena A., Loyon R., Suffiotti M., Salvestrini V., Wyss T., Vanoni G., Ruan D.F., Rossi M., Tozzo A. et al., 2019/11/26. Blood advances, 3 (22) pp. 3674-3687. Peer-reviewed.

[DOI][Pmid][serval:BIB_4BC26C680B22]

Towards Quantification of Inflammation in Atherosclerotic Plaque in the Clinic - Characterization and Optimization of Fluorine-19 MRI in Mice at 3 T.

Darçot E., Colotti R., Pellegrin M., Wilson A., Siegert S., Bouzourene K., Yerly J., Mazzolai L., Stuber M., van Heeswijk R.B., 2019/11/25. Scientific reports, 9 (1) p. 17488. Peer-reviewed.

[DOI][Pmid][serval:BIB_40394E9CBB35]

Strong Enrichment of Aromatic and Sulfur-Containing Residues in Ligand-Protein Binding Sites.

El Hage K., Zoete V., 2019/11/25. Journal of chemical information and modeling, 59 (11) pp. 4921-4928. Peer-reviewed.

[DOI][Pmid][serval:BIB_8964B650737F]

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment.

Newey A., Griffiths B., Michaux J., Pak H.S., Stevenson B.J., Woolston A., Semiannikova M., Spain G., Barber L.J., Matthews N. et al., 2019/11/18. Journal for immunotherapy of cancer, 7 (1) p. 309. Peer-reviewed.

[DOI][Pmid][serval:BIB_7418AE3DFDA7]

Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes.

Racle J., Michaux J., Rockinger G.A., Arnaud M., Bobisse S., Chong C., Guillaume P., Coukos G., Harari A., Jandus C. et al., 2019/11. Nature biotechnology, 37 (11) pp. 1283-1286. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_D9A8D08A5BC6]

Intratumoral CD8<sup>+</sup> T cells with stem cell-like properties: Implications for cancer immunotherapy.

Held W., Siddiqui I., Schaeuble K., Speiser D.E., 2019/10/23. Science translational medicine, 11 (515). Peer-reviewed.

[DOI][Pmid][serval:BIB_2890415E8A72]

CDK4 Regulates Lysosomal Function and mTORC1 Activation to Promote Cancer Cell Survival.

Martínez-Carreres L., Puyal J., Leal-Esteban L.C., Orpinell M., Castillo-Armengol J., Giralt A., Dergai O., Moret C., Barquissau V., Nasrallah A. et al., 2019/10/15. Cancer research, 79 (20) pp. 5245-5259. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_78F7CC0E31B9]

Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1).

Röhrig U.F., Reynaud A., Majjigapu S.R., Vogel P., Pojer F., Zoete V., 2019/10/10. Journal of medicinal chemistry, 62 (19) pp. 8784-8795. Peer-reviewed.

[DOI][Pmid][serval:BIB_D8CCFFB94292]

Application of the SwissDrugDesign Online Resources in Virtual Screening.

Daina A., Zoete V., 2019/09/18. International journal of molecular sciences, 20 (18) p. 4612. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B934FE45EAA7]

Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches.

Digklia A., Duran R., Homicsko K., Kandalaft L.E., Hocquelet A., Orcurto A., Coukos G., Denys A., 2019/09. Cardiovascular and interventional radiology, 42 (9) pp. 1221-1229. Peer-reviewed.

[DOI][Pmid][serval:BIB_13E5E5B29D1D]

Biomodulina T partially restores immunosenescent CD4 and CD8 T cell compartments in the elderly.

Saavedra D., Fuertes S.A., Suárez G.M., González A., Lorenzo-Luaces P., García B., Aznar E., Mazorra Z., Crombet T., Speiser D.E. et al., 2019/09. Experimental gerontology, 124 p. 110633. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6E061DCF6353]

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients

Bassani-Sternberg Michal, Digklia Antonia, Huber Florian, Wagner Dorothea, Sempoux Christine, Stevenson Brian J., Thierry Anne-Christine, Michaux Justine, Pak HuiSong, Racle Julien et al., 2019/08/08. Frontiers in Immunology, 10. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0144F5D289B5]

Epigenetic Control of Mitochondrial Fission Enables Self-Renewal of Stem-like Tumor Cells in Human Prostate Cancer

Civenni Gianluca, Bosotti Roberto, Timpanaro Andrea, Vàzquez Ramiro, Merulla Jessica, Pandit Shusil, Rossi Simona, Albino Domenico, Allegrini Sara, Mitra Abhishek et al., 2019/08. Cell Metabolism, 30 (2) pp. 303-318.e6. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_160F9BD5E05B]

Rational combinations of immunotherapy with radiotherapy in ovarian cancer.

Herrera F.G., Irving M., Kandalaft L.E., Coukos G., 2019/08. The Lancet. Oncology, 20 (8) pp. e417-e433. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B919A825548B]

18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.

Jreige M., Letovanec I., Chaba K., Renaud S., Rusakiewicz S., Cristina V., Peters S., Krueger T., de Leval L., Kandalaft L.E. et al., 2019/08. European journal of nuclear medicine and molecular imaging, 46 (9) pp. 1859-1868. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4F575C6723CE]

Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.

Yu Y.R., Ho P.C., 2019/08. Clinical and experimental immunology, 197 (2) pp. 153-160. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4F2A32ECC9A7]

High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T Cells.

Costa-Nunes C., Cachot A., Bobisse S., Arnaud M., Genolet R., Baumgaertner P., Speiser D.E., Sousa Alves P.M., Sandoval F., Adotévi O. et al., 2019/07/15. Clinical cancer research, 25 (14) pp. 4320-4331. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_99ED3D648751]

Masters thesis

Publications (1)

CANCER IMMUNOTHERAPY WITH VEGFR-3 TARGETED CAR T-CELLS

KIRITSIS K., 2016. 32, Université de Lausanne, Faculté de biologie et médecineCOUKOS G. (dir.).

[URN][serval:BIB_AD0E970E95CE]

Phd thesis

Publications (5)

Molecular and functional immune determinants associated with the optimal immunogenicity of Yellow Fever vaccination in humans

Bovay Amandine Xuan Kim, 2019/06/07., Université de Lausanne, Faculté de biologie et médecineSpeiser Daniel (dir.).

[URN][serval:BIB_5EBE536D2CB3]

Cytolytic CD4 T cells: Analysis of a novel T cell candidate for human tumor immunotherapy

Cachot Amélie, 2019., Université de Lausanne, Faculté de biologie et médecineRomero Pedro (dir.).

[serval:BIB_F0A6BE95CE46]

Molecular determinants governing CD8+ T cell mediated anti-tumor immunity

Martinez-Usatorre Amaia, 2018/04/27. 117, Université de Lausanne, Faculté de biologie et médecineRomero Pedro (dir.).

[URN][serval:BIB_08CEE3B79D75]

Harnessing iNKT and CD8 T cells for Immunotherapy of Cancer

Tschumi Benjamin Olivier, 2018/03/13. 117, Université de Lausanne, Faculté de biologie et médecineRomero Pedro (dir.).

[URN][serval:BIB_786BC3B46C6D]

Characterization of local and systemic immune-modulation in melanoma patients

Bordy N., 2015. 204, Université de Lausanne, Faculté de biologie et médecineSpeiser D., Swartz M. (dir.).

[URN][serval:BIB_9F9512EEBA1F]